Renalase Protein Could Help with Early Detection of Pancreatic Cancer
Pancreatic cancer is a rare, yet extremely deadly type of cancer, affecting approximately 46,000 Americans in 2014 and killing 40,000 more. One of the reasons this type of cancer has a high mortality rate is due to the difficulty of diagnosing the disease at an earlier and treatable stage. However, research into cancer biomarkers, published in Scientific Reports, may have found a way to improve early detection and treatment.
Researchers at the Yale University School of Medicine have taken a second look at a previously studied protein: renalase. The head of research for this study, Professor Gary Desir, discovered renalase in 2005 while looking for an explanation of why patients with renal failure also had a high incidence of heart disease.
Renalase, a protein created and released by many types of cancer cells, is abundantly present in pancreatic cancer patients. While investigating antibodies for renalase, the team discovered that the protein seems to work as a growth factor for those pancreatic cancer tumor cells. The team found that a higher rate of renalase meant a lower rate a survival. Researchers are now looking to use it as a biomarker for early cancer detection.
Early detection of any cancer is a key component of survival and remission. As medical technology improves and doctors are able to develop improved tests, they are hoping to be able to identify and administer treatment faster for cancer patients, raising the chances of survival.
A Cancer Diagnosis Could Qualify You for Disability Benefits
The Social Security Administration offers disability benefits and financial aid for low-income disabled individuals through several programs. To find out if you qualify, or for help with an appeal on a denied benefit claim, call the Disability Help Group. Contact us at 800-800-2009 to schedule a consultation with one of our disability advocates.